Bio Essence CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
Bio Essence Corp. reported a significant turnaround to net income in 2025, driven by a strategic shift to OEM services, despite ongoing litigation and internal control deficiencies.
OQB
Bio Essence Corp.'s 2024 10-K filing reveals increased net losses and a going concern uncertainty, despite revenue generation from continuing operations following subsidiary disposals.
OQB
Bio Essence Corp. reports a net loss of $971,879 for 2023, impacted by decreased sales and increased operating expenses, while also selling a subsidiary for $300,000.